Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms

[1]  V. Mohan,et al.  Peroxisome proliferator‐activated receptor‐γ co‐activator‐1α (PGC‐1α) gene polymorphisms and their relationship to Type 2 diabetes in Asian Indians , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[2]  Mark I McCarthy,et al.  What makes a good genetic association study? , 2005, The Lancet.

[3]  D. Herrington.  Eliminating the improbable: Sherlock Holmes and standards of evidence in the genomic age. , 2005, Circulation.

[4]  T. Hansen,et al.  A prevalent amino acid polymorphism at codon 98 (Ala98Val) of the hepatocyte nuclear factor-1alpha is associated with maturity-onset diabetes of the young and younger age at onset of type 2 diabetes in Asian Indians. , 2005, Diabetes care.

[5]  B. Lerer,et al.  Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism , 2005, The Pharmacogenomics Journal.

[6]  H. Parving,et al.  Aldosterone escape during blockade of the renin–angiotensin–aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate , 2004, Diabetologia.

[7]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[8]  M. Fujishima,et al.  Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM , 1996, Diabetologia.

[9]  Peter Donnelly,et al.  A comparison of bayesian methods for haplotype reconstruction from population genotype data. , 2003, American journal of human genetics.

[10]  M. Acevedo,et al.  Microalbuminuria: is it a valid predictor of cardiovascular risk? , 2003, Cleveland Clinic journal of medicine.

[11]  T. Sharma,et al.  Z–2 aldose reductase allele and diabetic retinopathy in India , 2003, Ophthalmic genetics.

[12]  Derek Gordon,et al.  Errors and Linkage Disequilibrium Interact Multiplicatively When Computing Sample Sizes for Genetic Case-Control Association Studies , 2002, Pacific Symposium on Biocomputing.

[13]  Robert M. Anderson,et al.  Prevention or delay of type 2 diabetes. , 2004, Diabetes care.

[14]  J. Ott,et al.  Power and Sample Size Calculations for Case-Control Genetic Association Tests when Errors Are Present: Application to Single Nucleotide Polymorphisms , 2002, Human Heredity.

[15]  V. Mohan,et al.  Familial clustering of diabetic retinopathy in South Indian Type 2 diabetic patients , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[16]  E. Schleicher,et al.  Angiotensin II induces human TGF-β1 promoter activation: similarity to hyperglycaemia , 2002, Diabetologia.

[17]  M Epstein,et al.  Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift , 2001, Journal of hypertension.

[18]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[19]  Ambady Ramachandran,et al.  Association between ACE gene polymorphism and diabetic nephropathy in South Indian patients. , 2001, JOP : Journal of the pancreas.

[20]  W. Grzeszczak,et al.  Angiotensinogen M235T and chymase gene CMA/B polymorphisms are not associated with nephropathy in type II diabetes. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  V. Mohan,et al.  Familial clustering of diabetic retinopathy in type 2 diabetic patients , 2000 .

[22]  P. de Knijff,et al.  Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.

[24]  J. Gross,et al.  Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. , 1999, Diabetes.

[25]  Ambady Ramachandran,et al.  Familial aggregation of diabetic kidney disease in Type 2 diabetes in south India. , 1999, Diabetes research and clinical practice.

[26]  R. Kunz,et al.  Association between the angiotensin-converting enzyme-insertion/deletion polymorphism and diabetic nephropathy: a methodologic appraisal and systematic review. , 1998, Journal of the American Society of Nephrology : JASN.

[27]  H. Parving,et al.  Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  A. Krolewski,et al.  Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM. , 1998, Hypertension.

[29]  T. Ogihara,et al.  Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy , 1998, Diabetologia.

[30]  J. Staessen,et al.  The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular‐renal risk , 1997, Journal of hypertension.

[31]  G Chatellier,et al.  Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. , 1997, The Journal of clinical investigation.

[32]  J. Staessen,et al.  The insertion/deletion polymorphism of the angiotensin-converting enzyme gene and car-diovascular-renal risk : a meta-analysis , 1997 .

[33]  G. Wolf,et al.  The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  W. Grzeszczak,et al.  Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy , 1996 .

[35]  A. Maxwell,et al.  A Molecular Variant of Angiotensinogen Is Associated With Diabetic Nephropathy in IDDM , 1996, Diabetes.

[36]  H. Parving,et al.  Nephrology Dialysis Transplantation Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy , 2005 .

[37]  G. Gearin,et al.  Angiotensinogen polymorphism M235T, hypertension, and nephropathy in insulin-dependent diabetes. , 1996, Hypertension.

[38]  H. Parving,et al.  Angiotensinogen Gene Polymorphisms in IDDM Patients With Diabetic Nephropathy , 1996, Diabetes.

[39]  I. Stratton,et al.  U.K. Prospective Diabetes Study. XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. , 1995, Kidney international.

[40]  E. Ritz,et al.  Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. , 1995, Kidney international.

[41]  H. Hemmi,et al.  Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. , 1995, Nephron.

[42]  O. Costerousse,et al.  Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. , 1993, The Biochemical journal.

[43]  Steven C. Hunt,et al.  Molecular basis of human hypertension: Role of angiotensinogen , 1992, Cell.

[44]  H. Parving,et al.  Is diabetic nephropathy an inherited complication? , 1992, Kidney international.

[45]  E. Seaquist,et al.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. , 1989, The New England journal of medicine.

[46]  F. Cambien,et al.  Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study. , 1988, American journal of human genetics.

[47]  W. Knowler,et al.  Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. , 1988, The New England journal of medicine.

[48]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[49]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.